HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 90/6/827    most recent expphysiol.2005.031252v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Howarth, F. C Articles by Adeghate, E Search for Related Content PubMed PubMed Citation Articles by Howarth, F. C Articles by Adeghate, E Related Collections Heart/Cardiac Muscle

¹ Department of Physiology² College Requirements Unit, Faculty of Engineering³ Department of Pharmacology, Faculty of Medicine & Health Sciences⁴ Department of Anatomy, Faculty of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates

In vivo biotelemetry studies have demonstrated that short-term streptozotocin (STZ)-induced diabetes is associated with a reduction in heart rate (HR) and heart rate variability (HRV) and prolongation of QT and QRS intervals. This study investigates the long-term effects of STZ-induced diabetes on the electrocardiogram (ECG), physical activity and body temperature. Transmitter devices were surgically implanted in the peritoneal cavity of young adult male Wistar rats. Electrodes from the transmitter were arranged in Einthoven bipolar lead II configuration. ECG, physical activity and body temperature data were continuously recorded with a telemetry system before and following the administration of STZ (60 mg kg^–1) for a period of 22 weeks. HR, physical activity and body temperature declined rapidly 3–5 days after the administration of STZ. The effects became conspicuous with time reaching a new steady state approximately 1–2 weeks after STZ treatment. HR at 4 weeks was 268 ± 5 beats min^–1 in diabetic rats compared to 347 ± 12 beats min^–1 in age-matched controls. HRV at 4 weeks was also significantly reduced after STZ treatment (18 ± 3 beats min^–1) compared to controls (33 ± 3 beats min^–1). HR and HRV were not additionally altered in either diabetic rats (266 ± 5 and 20 ± 4 beats min^–1) or age-matched controls (316 ± 6 and 25 ± 4 beats min^–1) at 22 weeks. Reduced physical activity and/or body temperature may partly underlie the reductions in HR and HRV. In addition, the increased power spectral low frequency/high frequency ratio from 4 weeks after STZ treatment may indicate an accompanying disturbance in sympathovagal balance.

(Received 10 June 2005; accepted after revision 2 August 2005; first published online 9 August 2005)
Corresponding author F. C. Howarth: Department of Physiology, Faculty of Medicine & Health Sciences, PO Box 17666, Al Ain, United Arab Emirates. Email: chris.howarth{at}uaeu.ac.ae

This article has been cited by other articles:

				F. C. Howarth, M. Jacobson, M. Shafiullah, and E. Adeghate Long-term effects of type 2 diabetes mellitus on heart rhythm in the Goto-Kakizaki rat Exp Physiol, March 1, 2008; 93(3): 362 - 369. [Abstract] [Full Text] [PDF]

				O. Rouyer, J. Zoll, F. Daussin, C. Damge, P. Helms, S. Talha, L. Rasseneur, F. Piquard, and B. Geny Muscle: Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats Exp Physiol, November 1, 2007; 92(6): 1047 - 1056. [Abstract] [Full Text] [PDF]

				A. Nygren, M. L. Olson, K. Y. Chen, T. Emmett, G. Kargacin, and Y. Shimoni Propagation of the cardiac impulse in the diabetic rat heart: reduced conduction reserve J. Physiol., April 15, 2007; 580(2): 543 - 560. [Abstract] [Full Text] [PDF]